OptimizeRx Corporation (OPRX)
Price:
18.75 USD
( + 1.15 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
HealthEquity, Inc.
VALUE SCORE:
8
2nd position
CareCloud, Inc.
VALUE SCORE:
9
The best
Progyny, Inc.
VALUE SCORE:
9
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
NEWS
OptimizeRx Corp. (OPRX) is a Great Momentum Stock: Should You Buy?
zacks.com
2025-10-02 13:01:22Does OptimizeRx Corp. (OPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off?
zacks.com
2025-09-30 11:05:15OPRX posts 55% revenue growth and raises outlook as AI-driven workflow integration fuels leverage and pharma adoption.
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
globenewswire.com
2025-09-10 07:30:00WALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference taking place Thursday, September 11, 2025, in New York, NY.
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
globenewswire.com
2025-09-09 16:05:00Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood ® Targeting Data with Lamar's Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing
Best Growth Stocks to Buy for September 5th
zacks.com
2025-09-05 10:26:16OPRX, KT and GLDD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 5, 2025.
Best Growth Stocks to Buy for September 3rd
zacks.com
2025-09-03 08:55:54OPRX, PHIN and KT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 3, 2025.
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now?
zacks.com
2025-09-01 13:01:19Does OptimizeRx Corp. (OPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
All You Need to Know About OptimizeRx (OPRX) Rating Upgrade to Strong Buy
zacks.com
2025-08-21 13:01:14OptimizeRx (OPRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stock to Buy for August 21st
zacks.com
2025-08-21 11:01:29OPRX, BZ and ANET made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 21, 2025.
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
globenewswire.com
2025-08-19 07:30:00WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced organizational updates and leadership advancements designed to accelerate the Company's Rule of 40 strategy—balancing sustained growth with increased profitability. These changes reflect the strength of the Company's leadership bench and CEO Steve Silvestro's commitment to aligning talent and structure with OptimizeRx's long-term strategic objectives under his management.
OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-08-08 15:26:46OptimizeRx Corporation (NASDAQ:OPRX ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Andrew Jacob D'Silva - Senior Vice President of Corporate Finance Edward Stelmakh - CFO & COO Stephen L. Silvestro - President & CEO Conference Call Participants Anderson Schock - B.
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates
zacks.com
2025-08-07 18:56:10OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.02 per share a year ago.
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
globenewswire.com
2025-08-07 16:01:00WALTHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today reported results for the three months ended June 30, 2025. Quarterly comparisons are to the same year-ago period.
Best Growth Stocks to Buy for August 7th
zacks.com
2025-08-07 10:20:19Here are three stocks with buy ranks and strong growth characteristics for investors to consider today August 7th:
Best Growth Stocks to Buy for August 5th
zacks.com
2025-08-05 10:11:20Here are three stocks with buy ranks and strong growth characteristics for investors to consider today August 5th:
Best Growth Stocks to Buy for August 1st
zacks.com
2025-08-01 06:06:04OPRX, JBL and ADRNY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 1, 2025.
No data to display
OptimizeRx Corp. (OPRX) is a Great Momentum Stock: Should You Buy?
zacks.com
2025-10-02 13:01:22Does OptimizeRx Corp. (OPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off?
zacks.com
2025-09-30 11:05:15OPRX posts 55% revenue growth and raises outlook as AI-driven workflow integration fuels leverage and pharma adoption.
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
globenewswire.com
2025-09-10 07:30:00WALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference taking place Thursday, September 11, 2025, in New York, NY.
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
globenewswire.com
2025-09-09 16:05:00Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood ® Targeting Data with Lamar's Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing
Best Growth Stocks to Buy for September 5th
zacks.com
2025-09-05 10:26:16OPRX, KT and GLDD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 5, 2025.
Best Growth Stocks to Buy for September 3rd
zacks.com
2025-09-03 08:55:54OPRX, PHIN and KT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 3, 2025.
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now?
zacks.com
2025-09-01 13:01:19Does OptimizeRx Corp. (OPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
All You Need to Know About OptimizeRx (OPRX) Rating Upgrade to Strong Buy
zacks.com
2025-08-21 13:01:14OptimizeRx (OPRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stock to Buy for August 21st
zacks.com
2025-08-21 11:01:29OPRX, BZ and ANET made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 21, 2025.
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
globenewswire.com
2025-08-19 07:30:00WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced organizational updates and leadership advancements designed to accelerate the Company's Rule of 40 strategy—balancing sustained growth with increased profitability. These changes reflect the strength of the Company's leadership bench and CEO Steve Silvestro's commitment to aligning talent and structure with OptimizeRx's long-term strategic objectives under his management.
OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-08-08 15:26:46OptimizeRx Corporation (NASDAQ:OPRX ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Andrew Jacob D'Silva - Senior Vice President of Corporate Finance Edward Stelmakh - CFO & COO Stephen L. Silvestro - President & CEO Conference Call Participants Anderson Schock - B.
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates
zacks.com
2025-08-07 18:56:10OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.02 per share a year ago.
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
globenewswire.com
2025-08-07 16:01:00WALTHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today reported results for the three months ended June 30, 2025. Quarterly comparisons are to the same year-ago period.
Best Growth Stocks to Buy for August 7th
zacks.com
2025-08-07 10:20:19Here are three stocks with buy ranks and strong growth characteristics for investors to consider today August 7th:
Best Growth Stocks to Buy for August 5th
zacks.com
2025-08-05 10:11:20Here are three stocks with buy ranks and strong growth characteristics for investors to consider today August 5th:
Best Growth Stocks to Buy for August 1st
zacks.com
2025-08-01 06:06:04OPRX, JBL and ADRNY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 1, 2025.